Autophagy in breast cancer and its implications for therapy

Area of Science:

• Cellular Biology
• Oncology
• Molecular Medicine

Background:

• Autophagy is a fundamental cellular process for degrading and recycling damaged components.
• Its role in cancer is complex, with evidence suggesting both tumor suppressive and tumor promoting functions.
• The autophagy-related gene BECN1's deletion in breast tumors initially pointed to a tumor suppressive role.

Purpose of the Study:

• To review the current literature on autophagy's role in breast cancer development and progression.
• To discuss the potential of targeting autophagy for breast cancer treatment strategies.

Main Methods:

• Comprehensive review of existing scientific literature.
• Analysis of studies investigating autophagy's involvement in various cancer-related cellular stresses.
• Evaluation of preclinical and clinical data on autophagy modulators in breast cancer models.

Main Results:

• Tumor cells frequently exploit autophagy to survive oncogenic stress, hypoxia, and detachment.
• Autophagy induction by cancer cells contributes to tumor dormancy and resistance to therapies.
• BECN1's role is more nuanced than initially suggested, with autophagy often supporting tumor progression.

Conclusions:

• Autophagy is increasingly recognized as a key player in breast cancer progression and therapeutic resistance.
• Autophagy inhibitors represent a promising therapeutic avenue for breast cancer treatment.
• Further research is essential to fully elucidate autophagy's precise role and optimize therapeutic targeting.